Question 1

What does the Global Mammography Horizon report cover?

Accepted Answer

The report covers the global mammography market and broader breast imaging ecosystem from 2024A to 2035F. It includes dedicated mammography systems, FFDM, digital breast tomosynthesis, contrast-enhanced mammography, mammography AI/workflow, service and aftermarket, mobile mammography, interventional breast pathways, breast ultrasound, and breast MRI adjacencies.

Question 2

Which companies are discussed in the report?

Accepted Answer

The report discusses systems OEMs, AI vendors, workflow platforms, interventional breast pathway companies, provider networks, mobile access models, China/value-tier challengers, detector suppliers, and CEM/photon-counting enabling-stack companies. Examples include Hologic, GE HealthCare, Siemens Healthineers, Fujifilm, Canon Medical, United Imaging, Wandong, ScreenPoint, Lunit/Volpara, RadNet/DeepHealth/iCAD, Visage/Pro Medicus, Sectra, Mammotome, BD, Merit Medical, Varex, Bayer, Bracco, and Guerbet.

Question 3

What is the Core Mammography Market?

Accepted Answer

The Core Mammography Market includes dedicated mammography systems, mammography-specific service contracts, mammography-specific software and workstations, and mammography AI/workflow revenue. It does not blend in breast biopsy, breast ultrasound, or breast MRI without explicit bridge labeling.

Question 4

How does the report treat AI revenue?

Accepted Answer

The report separates vendor-net AI/workflow revenue from provider-gross AI economics. Vendor-net revenue refers to software revenue booked by vendors, OEMs, or workflow platforms. Provider-gross economics include productivity, patient-pay, reimbursement, recall management, and downstream workflow value captured by providers.

Question 5

How is this report different from a standard mammography equipment market report?

Accepted Answer

A standard equipment report often focuses on unit shipments, installed base, ASPs, and system revenue. This Horizon report adds market-structure analysis, AI monetization, CEM strategy, interventional breast pathway economics, breast US/MRI adjacencies, regional archetypes, competitive control planes, and strategic frameworks for commercial decision-making.

Question 6

Who should buy this report?

Accepted Answer

This report is designed for medical imaging OEMs, breast health strategy teams, AI and workflow vendors, enterprise imaging platforms, biopsy and interventional breast companies, detector and contrast suppliers, provider networks, investors, private equity, distributors, and public-sector screening or procurement stakeholders.

Industry Coverage: Digital Health & AI

Fusion Core Service

Global Oncology Imaging AI Market Pulse 2025–2032 Size, Mix and Momentum

Oncology Imaging AI Strategy Pulse 2025–2032 — Pathways, Platforms & Playbooks

MEA (Middle East & Africa) AI-assisted Medical Imaging Market 2025

APAC AI-assisted Medical Imaging Market 2025

LATAM AI-assisted Medical Imaging Market 2025

Europe AI-assisted Medical Imaging Market 2025

World Market for CT Scanners

World Market for Digital Pathology & Whole Slide Imaging

World Market for Teleradiology

Quick Links

Solutions

Contact us